# FDA 483 - Dr. Reddy's Laboratories Ltd. - July 29, 2026

Source: https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/5dd3cfe2-65cc-41a5-9898-5c918afcb941

> FDA 483 for Dr. Reddy's Laboratories Ltd. on July 29, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Dr. Reddy's Laboratories Ltd.
- Inspection Date: 2026-07-29
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: Dr. Reddy's Laboratories Ltd. was cited with three observations during an FDA inspection of its human prescription drug manufacturing facility in Ranasthalam Mandal, India. The inspection revealed deficiencies in laboratory controls for in-process materials, inadequate identity testing of incoming components, and a lack of systems to ensure compliance with DSCSA verification requirements. These issues indicate significant concerns regarding product quality, purity, and supply chain integrity for drugs distributed to the U.S. market.

## Related Documents

- [483 - 2023-05-12](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/07b5462e-7e29-4956-b928-9ffe0e4f41df)
- [483 - 2023-05-12](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/d70d3ff3-a23c-4d1b-b3d0-b772ff1d78db)

## Related Officers

- [Ronda R. Loyd Jones](https://www.keypedia.com/people/ronda-r-loyd-jones/b10f3112-6439-4182-855f-f1be491d1f39)
- [Milton J. De Jesus Tavarez](https://www.keypedia.com/people/milton-j-de-jesus-tavarez/24d4ed81-7c7e-42d2-8888-1c56c25eec67)

Company: https://www.keypedia.com/companies/dr-reddys-laboratories-ltd/769ee88d-49d7-4a19-b97a-63ec71cb7114

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3